(Q37287413)

English

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

scientific article published on 30 June 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

0 references

0 references

0 references

Armando Santoro

1 reference

ORCID Public Data File 2021

author name string

V Gregorc

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

A Santoro

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

E Bennicelli

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

C J A Punt

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

G Citterio

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

J N H Timmer-Bonte

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

F Caligaris Cappio

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

A Lambiase

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

C Bordignon

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

C M L van Herpen

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

30 June 2009

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

101

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

219-224

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Targeted agents: the rules of combination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

6 September 2017

American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

6 September 2017

Impaired angiogenesis in aminopeptidase N-null mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

6 September 2017

Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

6 September 2017

Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

6 September 2017

Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

6 September 2017

Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

6 September 2017

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

6 September 2017

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

14 September 2017

Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

28 September 2017

Phase I trial of recombinant human tumour necrosis factor α in patients with advanced malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

28 September 2017

Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720203

3 September 2018

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605162

21 January 2018

A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6605162

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37287413&oldid=2200129695"